Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1 (Q82567338)
Jump to navigation
Jump to search
scientific article published on 17 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1 |
scientific article published on 17 November 2011 |
Statements
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1 (English)
Jean Philippe Arnault
Christine Mateus
Bernard Escudier
Gorana Tomasic
Janine Wechsler
Emilie Hollville
Jean-Charles Soria
David Malka
Alain Sarasin
Magalie Larcher
Jocelyne André
Nyam Kamsu-Kom
Ludovic Lacroix
Alain Spatz
Alexander M Eggermont
Nicolas Dumaz
Caroline Robert
17 November 2011